Authors
Loading...
This patent review highlights the growth of BTK inhibitors in B-cell malignancies and autoimmune diseases, suggesting their promising therapeutic potential.
Cui et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: